Windtree Therapeutics
(NASDAQ:WINT)
Windtree Therapeutics, Inc. - Common Stock is expected to split Monday, August 15, 2022 with a ratio of 1:5
Windtree Therapeutics, Inc. - Common Stock recently split on Friday, August 12, 2022 with a ratio of 1:3
$0.397
0.0081[2.08%]
At close: Aug 12
$0.405
0.0080[2.02%]
After Hours: 5:43PM EDT
Day High/Low0.37 - 0.43
52 Week High/Low0.35 - 1.63
Open / Close0.43 / 0.4
Float / Outstanding21.8M / 29.4M
Vol / Avg.200.4K / 241K
Mkt Cap11.7M
P/E-
50d Avg. Price0.42
Div / Yield-
Payout Ratio-
EPS-0.29
Total Float21.8M

Windtree Therapeutics (NASDAQ:WINT), Quotes and News Summary

Windtree Therapeutics (NASDAQ: WINT)

Day High/Low0.37 - 0.43
52 Week High/Low0.35 - 1.63
Open / Close0.43 / 0.4
Float / Outstanding21.8M / 29.4M
Vol / Avg.200.4K / 241K
Mkt Cap11.7M
P/E-
50d Avg. Price0.42
Div / Yield-
Payout Ratio-
EPS-0.29
Total Float21.8M
Sector: Health Care.Industry: Biotechnology
Windtree Therapeutics Inc is a development-stage biotechnology company focused on developing KL4 surfactant therapies for respiratory diseases. Its technology platform includes synthetic, peptide-containing surfactant and novel drug delivery technologies that deliver aerosolized KL4 surfactants without invasive procedures. Its development program utilizing its proprietary technology platform is AEROSURF which is being developed for the treatment of respiratory distress syndrome in premature infants. It operates in the business segment of research and development of products focused on surfactant therapies for respiratory disorders and diseases, and the manufacture and commercial sales of approved products.

Earnings

see more
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-12-20
REV
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-11-09
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Windtree Therapeutics Questions & Answers

Q
How do I buy Windtree Therapeutics (WINT) stock?
A

You can purchase shares of Windtree Therapeutics (NASDAQ: WINT) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Windtree Therapeutics's (WINT) competitors?
Q
What is the target price for Windtree Therapeutics (WINT) stock?
A

The latest price target for Windtree Therapeutics (NASDAQ: WINT) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting WINT to rise to within 12 months (a possible 907.56% upside). 50 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Windtree Therapeutics (WINT)?
A

The stock price for Windtree Therapeutics (NASDAQ: WINT) is $0.397 last updated August 12, 2022, 7:59 PM UTC.

Q
Does Windtree Therapeutics (WINT) pay a dividend?
A

The next Windtree Therapeutics (WINT) dividend date is projected to be Thursday, September 1, 2022.

Q
When is Windtree Therapeutics (NASDAQ:WINT) reporting earnings?
A

Windtree Therapeutics’s FY earnings are confirmed for Wednesday, December 20, 2023.

Q
Is Windtree Therapeutics (WINT) going to split?
A

There is no upcoming split for Windtree Therapeutics.

Q
What sector and industry does Windtree Therapeutics (WINT) operate in?
A

Windtree Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.